

(Sharecast News) - Monoclonal antibody developer and supplier Bioventix reported an 8% fall in revenue in its first half on Monday, to £4.7m.


UK shareholder meetings calendar - next 7 days


IN BRIEF: Bioventix lifts payout as revenue rises, but profit slips


IN BRIEF: Bioventix reports first-half fall in profit, raises dividend


(Sharecast News) - Diagnostic antibody developer Bioventix reported a 1.3% improvement in revenue in its first half on Monday, to £5.2m.


UK Shareholder Meetings Calendar - Next 7 Days


IN BRIEF: Bioventix Hikes Dividend Payout As Annual Earnings Rise


UK EXECUTIVE CHANGE SUMMARY: New CFOs At Ideagen And Bioventix